Search research articles
Contact Us
Filters
Showing results (151-160 of 462) with videos related to
Page
of 47
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 30, 2021
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis
Neeraj Narula, Emily C L Wong, John K Marshall, et al.
Journal of Crohn'S & Colitis
|
May 3, 2018
Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease
Cindy C Y Law, Alisha Narula, Amy L Lightner, et al.
Inflammatory Bowel Diseases
|
July 22, 2015
Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study
Alexander Eser, Jean-Frederic Colombel, Paul Rutgeerts, et al.
Inflammatory Bowel Diseases
|
December 30, 2021
Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab
Parambir S Dulai, Emily C L Wong, Walter Reinisch, et al.
The American Journal of Gastroenterology
|
January 8, 2010
Herpes simplex virus meningoencephalitis in a patient with Crohn's disease on azathioprine therapy
Olivier Robineau, Juliette Enrico, Xavier Lemaire, et al.
Advances in Therapy
|
November 10, 2021
A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar
Walter Reinisch, Stanley Cohen, Monica Ramchandani, et al.
Inflammatory Bowel Diseases
|
September 18, 2010
Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine
Philippe Seksik, Jean-Yves Mary, Laurent Beaugerie, et al.
Journal of Crohn'S & Colitis
|
March 11, 2021
Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc Analysis
Neeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Gastroenterology
|
August 17, 2014
Converging goals of treatment of inflammatory bowel disease from clinical trials and practice
Barrett G Levesque, William J Sandborn, Joannie Ruel, et al.
Journal of Crohn'S & Colitis
|
September 15, 2020
Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn's Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials
Neeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Page
of 47
Search research articles
Search
Showing results (151-160 of 462) with videos related to
Sort By:
Page
of 47
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 30, 2021
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis
Neeraj Narula, Emily C L Wong, John K Marshall, et al.
Journal of Crohn'S & Colitis
|
May 3, 2018
Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease
Cindy C Y Law, Alisha Narula, Amy L Lightner, et al.
Inflammatory Bowel Diseases
|
July 22, 2015
Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study
Alexander Eser, Jean-Frederic Colombel, Paul Rutgeerts, et al.
Inflammatory Bowel Diseases
|
December 30, 2021
Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab
Parambir S Dulai, Emily C L Wong, Walter Reinisch, et al.
The American Journal of Gastroenterology
|
January 8, 2010
Herpes simplex virus meningoencephalitis in a patient with Crohn's disease on azathioprine therapy
Olivier Robineau, Juliette Enrico, Xavier Lemaire, et al.
Advances in Therapy
|
November 10, 2021
A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar
Walter Reinisch, Stanley Cohen, Monica Ramchandani, et al.
Inflammatory Bowel Diseases
|
September 18, 2010
Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine
Philippe Seksik, Jean-Yves Mary, Laurent Beaugerie, et al.
Journal of Crohn'S & Colitis
|
March 11, 2021
Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc Analysis
Neeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Gastroenterology
|
August 17, 2014
Converging goals of treatment of inflammatory bowel disease from clinical trials and practice
Barrett G Levesque, William J Sandborn, Joannie Ruel, et al.
Journal of Crohn'S & Colitis
|
September 15, 2020
Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn's Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials
Neeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Page
of 47